A study published Wednesday in the journal Science Translational Medicine examines the question: Why did one vaccine offer 35% less protection against the flu?
The less-effective vaccine failed to activate dendritic cells, which are key to the immune system's defense, the researchers discovered, and it failed to stimulate an early immune response.
